"Abortion access has been transformed by medication abortion pills. These pills have made safe abortion possible around the world, even in the most restrictive legal contexts. Abortion Beyond Borders follows these pills as they are moved by feminist activists from India into Ireland, Northern Ireland, Poland and the USA. It explores how medication abortion pills and the activists who supply them have changed abortion access, impacted politics, and catalyzed progressive reforms. Abortion Beyond Borders offers an unprecedented, up-close look into the global self-managed abortion movement"--

An unprecedented, up-close look into the global self-managed abortion movement. Abortion pills have made safe medication abortion possible for millions of people around the world, even in the most restrictive circumstances. In this timely book, Sydney Calkin illustrates the profound, transformative promise of these pills—which are safe, effective, and responsible for a sharp decline in maternal mortality. Abortion Pills Go Global demonstrates that the widespread practice of self-managed medication abortion makes it more difficult for countries to enforce oppressive abortion laws and less willing to do so. Taking a bold and unique geographic approach, this book follows these pills as they are manufactured and transported by feminist activists from India to Ireland, Northern Ireland, Poland, and the United States. Calkin shows that the growing availability of abortion pills in places with restrictive laws means more people have access to self-managed healthcare. Abortion Pills Go Global looks ahead to see how the broader politics of abortion could shift in response to this global movement—one that looks not to laws for protection but to on-the-ground feminist mobilizations across borders.

"Abortion access has been transformed by medication abortion pills. These pills have made safe abortion possible around the world, even in the most restrictive legal contexts. Abortion Beyond Borders follows these pills as they are moved by feminist activists from India into Ireland, Northern Ireland, Poland and the USA. It explores how medication abortion pills and the activists who supply them have changed abortion access, impacted politics, and catalyzed progressive reforms. Abortion Beyond Borders offers an unprecedented, up-close look into the global self-managed abortion movement"--

At a UN General Assembly Special Session in 1999, governments recognised unsafe abortion as a major public health concern, and pledged their commitment to reduce the need for abortion through expanded and improved family planning services, as well as ensure abortion services should be safe and accessible. This technical and policy guidance provides a comprehensive overview of the many actions that can be taken in health systems to ensure that women have access to good quality abortion services as allowed by law.

This open access edited book brings together new research on the mechanisms by which maternal and reproductive health policies are formed and implemented in diverse locales around the world, from global policy spaces to sites of practice. The authors – both internationally respected anthropologists and new voices – demonstrate the value of ethnography and the utility of reproduction as a lens through which to generate rich insights into professionals’ and lay people’s intimate encounters with policy. Authors look closely at core policy debates in the history of global maternal health across six different continents, including: Women’s use of misoprostol for abortion in Burkina Faso The place of traditional birth attendants in global maternal health Donor-driven maternal health programs in Tanzania Efforts to integrate qualitative evidence in WHO maternal and child health policy-making Anthropologies of Global Maternal and Reproductive Health will engage readers interested in critical conversations about global health policy today. The broad range of foci makes it a valuable resource for teaching in medical anthropology, anthropology of reproduction, and interdisciplinary global health programs. The book will also find readership amongst critical public health scholars, health policy and systems researchers, and global public health practitioners.

This is the first book to offer a comprehensive history of abortion pills in the United States. Public intellectual and lawyer Carrie N. Baker shows how courageous activists waged a decades-long campaign to establish, expand, and maintain access to abortion pills. Weaving their voices throughout her book, Baker recounts both dramatic and everyday acts of their resistance. These activists battled anti-abortion forces, overly cautious policymakers, medical gatekeepers, and fearful allies in their four-decade-long fight to free abortion pills. In post-Roe America, abortion pills are currently playing a critically important role in providing safe abortion access to tens of thousands of people living in states that now ban and restrict abortion. Understanding this struggle will help to ensure continued access into the future.

Bad products are recalled every day: the Ford Pinto, faulty tires, dangerous prescription pills, contaminated lettuce. If a product is found to pose even a modest risk to those who use it, you can bet it will soon be pulled from the market. . . . Unless that product is abortion.

Annotation. An award-winner when first published, this book has become a classic text for health activists and feminists interested in the complexities of how drugs are developed, marketed and sold to women around the world. In this book the authors review the unusual history of the French abortion pill, RU 486 (mifepristone). They scrutinize the science and politics from inception through to its use on women. Is RU 486 a miracle drug for abortion that is a safe and effective alternative to conventional abortion procedures? Does it privatise and de-medicalise the abortion experience? Is its availability a victory for women? Is RU 486 safe for use in Third World countries and remote rural areas? Who benefits from chemical abortion and how does RU 486 affect existing abortion services? The authors argue that the positive claims made for RU 486 (mifepristone) are filled with myths and misconceptions. RU 486 used on its own is a failed abortifacient and needs the addition of a prostaglandin, a dangerous drug. But the success'rates of the drug cocktail RU 486/prostaglandin remain at 92 to 95 per cent compared with 98 to 99 per cent for suction abortions. Suction abortions, which are best done with a local anaesthetic, involve no harmful drugs and are completed in 30 minutes. By contrast, RU 486/PG abortions last for days, sometimes weeks. Heavy bleeding, transfusions, vomiting, severe pain and infection are among the unpredictable adverse effects. Women have died from sepsis and cardiovascular events. RU 486/PG abortion benefits the medical profession, drug companies and government health economies. Through painstaking research and analysis the authors uncover the truth that chemical abortion is ill-conceived and unethical. They caution that low-tech abortion services are under threat as the mainstream hails RU 486 abortion as safe and effective'which it is not.

Why has punditry lately overtaken news? Why do lies seem to linger so long in the cultural subconscious even after they’ve been thoroughly discredited? And why, when more people than ever before are documenting the truth with laptops and digital cameras, does fact-free spin and propaganda seem to work so well? True Enough explores leading controversies of national politics, foreign affairs, science, and business, explaining how Americans have begun to organize themselves into echo chambers that harbor diametrically different facts—not merely opinions—from those of the larger culture.

The Clinical practice handbook for safe abortion care is intended to facilitate the practical application of the clinical recommendations from the second edition of Safe abortion: technical and policy guidance for health systems (World Health Organization [WHO] 2012). While legal, regulatory, policy and service-delivery contexts may vary from country to country, the recommendations and best practices described in both of these documents aim to enable evidence-based decision-making with respect to safe abortion care.